<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> remains the third most common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in both women and men worldwide </plain></SENT>
<SENT sid="1" pm="."><plain>Identifying modifiable dietary factors is crucial in developing primary prevention strategies </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="14" ids="27306">Vitamin B6</z:chebi> is involved in more than 100 coenzyme reactions, and may influence <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> risk in multiple ways including through its role in one-carbon metabolism related DNA synthesis and methylation and by reducing <z:mp ids='MP_0001845'>inflammation</z:mp>, cell proliferation, and <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Observational studies of dietary or dietary plus supplementary intake of <z:chebi fb="14" ids="27306">vitamin B6</z:chebi> and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> risk have been inconsistent with most studies reporting nonsignificant positive or inverse associations </plain></SENT>
<SENT sid="4" pm="."><plain>However, published studies of plasma <z:chebi fb="0" ids="18405">pyridoxal 5'-phosphate</z:chebi> (the active form of <z:chebi fb="14" ids="27306">vitamin B6</z:chebi>) levels consistently support an approximately 30%-50% reduction in risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> comparing high with low concentrations </plain></SENT>
<SENT sid="5" pm="."><plain>The reasons for the discrepancy in the results between dietary-based and plasma-based studies remain unresolved </plain></SENT>
<SENT sid="6" pm="."><plain>Other unresolved questions include the effects of <z:chebi fb="14" ids="27306">vitamin B6</z:chebi> intake in early life (i.e., childhood or adolescence) and of suboptimal <z:chebi fb="14" ids="27306">vitamin B6</z:chebi> status on <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> risk, whether the associations with <z:chebi fb="14" ids="27306">vitamin B6</z:chebi> differ across molecular subtypes of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, and whether the <z:chebi fb="14" ids="27306">vitamin B6</z:chebi>-<z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> association is modified by genetic variants of one-carbon metabolism </plain></SENT>
</text></document>